Conversion Rates of Induced Versus Spontaneous Ventricular Tachycardia by a Third Generation Cardioverter Defibrillator
- 1 January 1993
- journal article
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 16 (1), 170-173
- https://doi.org/10.1111/j.1540-8159.1993.tb01556.x
Abstract
Seventy consecutive patients received the first VENTAK PRx pulse generators (Cardiac Pacemakers, Inc.) implanted in the United States. This multiprogrammable device has therapeutic options that include: (1) antitachycardia pacing; (2) low energy cardioversion; (3) defihrillation shocks; and (4) bradycardia pacing. There were 60 males and 10 females with a mean age of 65.3 ± 9.4 years. The anatomical diagnoses were coronary artery disease in 55 patients, cardiomyopathy in 7 patients, congenital heart disease in 2 patients, and miscellaneous disease in the remaining 6 patients. Thirty‐six percent had a history of sudden cardiac death and 90% had documented monomorphic ventricular tachycardia. The mean ejection fraction was 32.7%± 12.2%. Thirty‐three (49.3%) had an ejection fraction ≤ 30%. Electrophysiological testing was done preimplant, predischarge, and 1 to 2 months postimplant to define a specific electrical therapy and evaluate the efficacy of the device. Two hundred ninety‐three of 367 (80%) episodes of induced ventricular tachycardia were successfully terminated by the VENTAK PRx programmed for antitachycardia pacing. There were 1,794 total therapy episodes for spontaneous ventricular tachycardia; 91% (1,641 episodes) were terminated by antitachycardia pacing and 153 episodes were converted by shocks during a minimal 6‐month follow‐up per patient. We conclude that documentation of a successful antitachycardia pacing modality in the electrophysiology laboratory predicts conversion of spontaneous episodes of ventricular tachycardia. Furthermore, antitachycardia pacing by the VENTAK PRx can terminate the majority of episodes of ventricular tachycardia.Keywords
This publication has 3 references indexed in Scilit:
- Ninety‐Six Episodes of Spontaneous Ventricular Tachycardia in 1 Week: Success of Ramp Pacing by a Pacer‐Cardioverter‐DefibrillatorPacing and Clinical Electrophysiology, 1991
- Reduction in defibrillator shocks with an implantable device combining antitachycardia pacing and shock therapyJournal of the American College of Cardiology, 1991
- Termination of ventricular tachycardia with bursts of rapid ventricular pacingThe American Journal of Cardiology, 1978